Global Natural Killer Cells Therapeutics Market Size, Status and Forecast 2024-2031

Report ID: 918778 | Published Date: Sep 2024 | No. of Page: 108 | Base Year: 2023 | Rating: 4.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Natural Killer Cells Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 NK Cell Therapies
        1.2.3 NK Cell Directed Antibodies
    1.3 Market by Application
        1.3.1 Global Natural Killer Cells Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Research Centers & Institutes
        1.3.3 Hospitals
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Natural Killer Cells Therapeutics Market Perspective (2016-2027)
    2.2 Natural Killer Cells Therapeutics Growth Trends by Regions
        2.2.1 Natural Killer Cells Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Natural Killer Cells Therapeutics Historic Market Share by Regions (2016-2021)
        2.2.3 Natural Killer Cells Therapeutics Forecasted Market Size by Regions (2022-2027)
    2.3 Natural Killer Cells Therapeutics Industry Dynamic
        2.3.1 Natural Killer Cells Therapeutics Market Trends
        2.3.2 Natural Killer Cells Therapeutics Market Drivers
        2.3.3 Natural Killer Cells Therapeutics Market Challenges
        2.3.4 Natural Killer Cells Therapeutics Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Natural Killer Cells Therapeutics Players by Revenue
        3.1.1 Global Top Natural Killer Cells Therapeutics Players by Revenue (2016-2021)
        3.1.2 Global Natural Killer Cells Therapeutics Revenue Market Share by Players (2016-2021)
    3.2 Global Natural Killer Cells Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Natural Killer Cells Therapeutics Revenue
    3.4 Global Natural Killer Cells Therapeutics Market Concentration Ratio
        3.4.1 Global Natural Killer Cells Therapeutics Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Natural Killer Cells Therapeutics Revenue in 2020
    3.5 Natural Killer Cells Therapeutics Key Players Head office and Area Served
    3.6 Key Players Natural Killer Cells Therapeutics Product Solution and Service
    3.7 Date of Enter into Natural Killer Cells Therapeutics Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Natural Killer Cells Therapeutics Breakdown Data by Type
    4.1 Global Natural Killer Cells Therapeutics Historic Market Size by Type (2016-2021)
    4.2 Global Natural Killer Cells Therapeutics Forecasted Market Size by Type (2022-2027)

5 Natural Killer Cells Therapeutics Breakdown Data by Application
    5.1 Global Natural Killer Cells Therapeutics Historic Market Size by Application (2016-2021)
    5.2 Global Natural Killer Cells Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Natural Killer Cells Therapeutics Market Size (2016-2027)
    6.2 North America Natural Killer Cells Therapeutics Market Size by Type
        6.2.1 North America Natural Killer Cells Therapeutics Market Size by Type (2016-2021)
        6.2.2 North America Natural Killer Cells Therapeutics Market Size by Type (2022-2027)
        6.2.3 North America Natural Killer Cells Therapeutics Market Size by Type (2016-2027)
    6.3 North America Natural Killer Cells Therapeutics Market Size by Application
        6.3.1 North America Natural Killer Cells Therapeutics Market Size by Application (2016-2021)
        6.3.2 North America Natural Killer Cells Therapeutics Market Size by Application (2022-2027)
        6.3.3 North America Natural Killer Cells Therapeutics Market Size by Application (2016-2027)
    6.4 North America Natural Killer Cells Therapeutics Market Size by Country
        6.4.1 North America Natural Killer Cells Therapeutics Market Size by Country (2016-2021)
        6.4.2 North America Natural Killer Cells Therapeutics Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Natural Killer Cells Therapeutics Market Size (2016-2027)
    7.2 Europe Natural Killer Cells Therapeutics Market Size by Type
        7.2.1 Europe Natural Killer Cells Therapeutics Market Size by Type (2016-2021)
        7.2.2 Europe Natural Killer Cells Therapeutics Market Size by Type (2022-2027)
        7.2.3 Europe Natural Killer Cells Therapeutics Market Size by Type (2016-2027)
    7.3 Europe Natural Killer Cells Therapeutics Market Size by Application
        7.3.1 Europe Natural Killer Cells Therapeutics Market Size by Application (2016-2021)
        7.3.2 Europe Natural Killer Cells Therapeutics Market Size by Application (2022-2027)
        7.3.3 Europe Natural Killer Cells Therapeutics Market Size by Application (2016-2027)
    7.4 Europe Natural Killer Cells Therapeutics Market Size by Country
        7.4.1 Europe Natural Killer Cells Therapeutics Market Size by Country (2016-2021)
        7.4.2 Europe Natural Killer Cells Therapeutics Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Natural Killer Cells Therapeutics Market Size (2016-2027)
    8.2 Asia-Pacific Natural Killer Cells Therapeutics Market Size by Type
        8.2.1 Asia-Pacific Natural Killer Cells Therapeutics Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Natural Killer Cells Therapeutics Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Natural Killer Cells Therapeutics Market Size by Type (2016-2027)
    8.3 Asia-Pacific Natural Killer Cells Therapeutics Market Size by Application
        8.3.1 Asia-Pacific Natural Killer Cells Therapeutics Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Natural Killer Cells Therapeutics Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Natural Killer Cells Therapeutics Market Size by Application (2016-2027)
    8.4 Asia-Pacific Natural Killer Cells Therapeutics Market Size by Region
        8.4.1 Asia-Pacific Natural Killer Cells Therapeutics Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Natural Killer Cells Therapeutics Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Natural Killer Cells Therapeutics Market Size (2016-2027)
    9.2 Latin America Natural Killer Cells Therapeutics Market Size by Type
        9.2.1 Latin America Natural Killer Cells Therapeutics Market Size by Type (2016-2021)
        9.2.2 Latin America Natural Killer Cells Therapeutics Market Size by Type (2022-2027)
        9.2.3 Latin America Natural Killer Cells Therapeutics Market Size by Type (2016-2027)
    9.3 Latin America Natural Killer Cells Therapeutics Market Size by Application
        9.3.1 Latin America Natural Killer Cells Therapeutics Market Size by Application (2016-2021)
        9.3.2 Latin America Natural Killer Cells Therapeutics Market Size by Application (2022-2027)
        9.3.3 Latin America Natural Killer Cells Therapeutics Market Size by Application (2016-2027)
    9.4 Latin America Natural Killer Cells Therapeutics Market Size by Country
        9.4.1 Latin America Natural Killer Cells Therapeutics Market Size by Country (2016-2021)
        9.4.2 Latin America Natural Killer Cells Therapeutics Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Natural Killer Cells Therapeutics Market Size (2016-2027)
    10.2 Middle East & Africa Natural Killer Cells Therapeutics Market Size by Type
        10.2.1 Middle East & Africa Natural Killer Cells Therapeutics Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Natural Killer Cells Therapeutics Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Natural Killer Cells Therapeutics Market Size by Type (2016-2027)
    10.3 Middle East & Africa Natural Killer Cells Therapeutics Market Size by Application
        10.3.1 Middle East & Africa Natural Killer Cells Therapeutics Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Natural Killer Cells Therapeutics Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Natural Killer Cells Therapeutics Market Size by Application (2016-2027)
    10.4 Middle East & Africa Natural Killer Cells Therapeutics Market Size by Country
        10.4.1 Middle East & Africa Natural Killer Cells Therapeutics Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Natural Killer Cells Therapeutics Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Affimed
        11.1.1 Affimed Company Details
        11.1.2 Affimed Business Overview
        11.1.3 Affimed Natural Killer Cells Therapeutics Introduction
        11.1.4 Affimed Revenue in Natural Killer Cells Therapeutics Business (2016-2021)
        11.1.5 Affimed Recent Development
    11.2 Celgene Corporation
        11.2.1 Celgene Corporation Company Details
        11.2.2 Celgene Corporation Business Overview
        11.2.3 Celgene Corporation Natural Killer Cells Therapeutics Introduction
        11.2.4 Celgene Corporation Revenue in Natural Killer Cells Therapeutics Business (2016-2021)
        11.2.5 Celgene Corporation Recent Development
    11.3 Fate Therapeutics
        11.3.1 Fate Therapeutics Company Details
        11.3.2 Fate Therapeutics Business Overview
        11.3.3 Fate Therapeutics Natural Killer Cells Therapeutics Introduction
        11.3.4 Fate Therapeutics Revenue in Natural Killer Cells Therapeutics Business (2016-2021)
        11.3.5 Fate Therapeutics Recent Development
    11.4 Fortress Biotech
        11.4.1 Fortress Biotech Company Details
        11.4.2 Fortress Biotech Business Overview
        11.4.3 Fortress Biotech Natural Killer Cells Therapeutics Introduction
        11.4.4 Fortress Biotech Revenue in Natural Killer Cells Therapeutics Business (2016-2021)
        11.4.5 Fortress Biotech Recent Development
    11.5 Glycostem Therapeutics
        11.5.1 Glycostem Therapeutics Company Details
        11.5.2 Glycostem Therapeutics Business Overview
        11.5.3 Glycostem Therapeutics Natural Killer Cells Therapeutics Introduction
        11.5.4 Glycostem Therapeutics Revenue in Natural Killer Cells Therapeutics Business (2016-2021)
        11.5.5 Glycostem Therapeutics Recent Development
    11.6 Innate Pharma
        11.6.1 Innate Pharma Company Details
        11.6.2 Innate Pharma Business Overview
        11.6.3 Innate Pharma Natural Killer Cells Therapeutics Introduction
        11.6.4 Innate Pharma Revenue in Natural Killer Cells Therapeutics Business (2016-2021)
        11.6.5 Innate Pharma Recent Development
    11.7 Nantkwest
        11.7.1 Nantkwest Company Details
        11.7.2 Nantkwest Business Overview
        11.7.3 Nantkwest Natural Killer Cells Therapeutics Introduction
        11.7.4 Nantkwest Revenue in Natural Killer Cells Therapeutics Business (2016-2021)
        11.7.5 Nantkwest Recent Development
    11.8 Nkarta Therapeutics
        11.8.1 Nkarta Therapeutics Company Details
        11.8.2 Nkarta Therapeutics Business Overview
        11.8.3 Nkarta Therapeutics Natural Killer Cells Therapeutics Introduction
        11.8.4 Nkarta Therapeutics Revenue in Natural Killer Cells Therapeutics Business (2016-2021)
        11.8.5 Nkarta Therapeutics Recent Development
    11.9 NKT Therapeutics
        11.9.1 NKT Therapeutics Company Details
        11.9.2 NKT Therapeutics Business Overview
        11.9.3 NKT Therapeutics Natural Killer Cells Therapeutics Introduction
        11.9.4 NKT Therapeutics Revenue in Natural Killer Cells Therapeutics Business (2016-2021)
        11.9.5 NKT Therapeutics Recent Development
    11.10 Ziopharm Oncology
        11.10.1 Ziopharm Oncology Company Details
        11.10.2 Ziopharm Oncology Business Overview
        11.10.3 Ziopharm Oncology Natural Killer Cells Therapeutics Introduction
        11.10.4 Ziopharm Oncology Revenue in Natural Killer Cells Therapeutics Business (2016-2021)
        11.10.5 Ziopharm Oncology Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Natural Killer Cells Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of NK Cell Therapies
    Table 3. Key Players of NK Cell Directed Antibodies
    Table 4. Global Natural Killer Cells Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 5. Global Natural Killer Cells Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global Natural Killer Cells Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
    Table 7. Global Natural Killer Cells Therapeutics Market Share by Regions (2016-2021)
    Table 8. Global Natural Killer Cells Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 9. Global Natural Killer Cells Therapeutics Market Share by Regions (2022-2027)
    Table 10. Natural Killer Cells Therapeutics Market Trends
    Table 11. Natural Killer Cells Therapeutics Market Drivers
    Table 12. Natural Killer Cells Therapeutics Market Challenges
    Table 13. Natural Killer Cells Therapeutics Market Restraints
    Table 14. Global Natural Killer Cells Therapeutics Revenue by Players (2016-2021) & (US$ Million)
    Table 15. Global Natural Killer Cells Therapeutics Market Share by Players (2016-2021)
    Table 16. Global Top Natural Killer Cells Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Natural Killer Cells Therapeutics as of 2020)
    Table 17. Ranking of Global Top Natural Killer Cells Therapeutics Companies by Revenue (US$ Million) in 2020
    Table 18. Global 5 Largest Players Market Share by Natural Killer Cells Therapeutics Revenue (CR5 and HHI) & (2016-2021)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Natural Killer Cells Therapeutics Product Solution and Service
    Table 21. Date of Enter into Natural Killer Cells Therapeutics Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Natural Killer Cells Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 24. Global Natural Killer Cells Therapeutics Revenue Market Share by Type (2016-2021)
    Table 25. Global Natural Killer Cells Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 26. Global Natural Killer Cells Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 27. Global Natural Killer Cells Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
    Table 28. Global Natural Killer Cells Therapeutics Revenue Market Share by Application (2016-2021)
    Table 29. Global Natural Killer Cells Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 30. Global Natural Killer Cells Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 31. North America Natural Killer Cells Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 32. North America Natural Killer Cells Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 33. North America Natural Killer Cells Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 34. North America Natural Killer Cells Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 35. North America Natural Killer Cells Therapeutics Market Size by Country (2016-2021) & (US$ Million) 
    Table 36. North America Natural Killer Cells Therapeutics Market Size by Country (2022-2027) & (US$ Million) 
    Table 37. Europe Natural Killer Cells Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 38. Europe Natural Killer Cells Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 39. Europe Natural Killer Cells Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 40. Europe Natural Killer Cells Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 41. Europe Natural Killer Cells Therapeutics Market Size by Country (2016-2021) & (US$ Million) 
    Table 42. Europe Natural Killer Cells Therapeutics Market Size by Country (2022-2027) & (US$ Million) 
    Table 43. Asia-Pacific Natural Killer Cells Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 44. Asia-Pacific Natural Killer Cells Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 45. Asia-Pacific Natural Killer Cells Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 46. Asia-Pacific Natural Killer Cells Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 47. Asia-Pacific Natural Killer Cells Therapeutics Market Size by Region (2016-2021) & (US$ Million) 
    Table 48. Asia-Pacific Natural Killer Cells Therapeutics Market Size by Region (2022-2027) & (US$ Million) 
    Table 49. Latin America Natural Killer Cells Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 50. Latin America Natural Killer Cells Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 51. Latin America Natural Killer Cells Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 52. Latin America Natural Killer Cells Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 53. Latin America Natural Killer Cells Therapeutics Market Size by Country (2016-2021) & (US$ Million) 
    Table 54. Latin America Natural Killer Cells Therapeutics Market Size by Country (2022-2027) & (US$ Million) 
    Table 55. Middle East & Africa Natural Killer Cells Therapeutics Market Size by Type (2016-2021) (US$ Million)
    Table 56. Middle East & Africa Natural Killer Cells Therapeutics Market Size by Type (2022-2027) & (US$ Million)
    Table 57. Middle East & Africa Natural Killer Cells Therapeutics Market Size by Application (2016-2021) (US$ Million)
    Table 58. Middle East & Africa Natural Killer Cells Therapeutics Market Size by Application (2022-2027) & (US$ Million)
    Table 59. Middle East & Africa Natural Killer Cells Therapeutics Market Size by Country (2016-2021) & (US$ Million) 
    Table 60. Middle East & Africa Natural Killer Cells Therapeutics Market Size by Country (2022-2027) & (US$ Million) 
    Table 61. Affimed Company Details
    Table 62. Affimed Business Overview
    Table 63. Affimed Natural Killer Cells Therapeutics Product
    Table 64. Affimed Revenue in Natural Killer Cells Therapeutics Business (2016-2021) & (US$ Million)
    Table 65. Affimed Recent Development
    Table 66. Celgene Corporation Company Details
    Table 67. Celgene Corporation Business Overview
    Table 68. Celgene Corporation Natural Killer Cells Therapeutics Product
    Table 69. Celgene Corporation Revenue in Natural Killer Cells Therapeutics Business (2016-2021) & (US$ Million)
    Table 70. Celgene Corporation Recent Development
    Table 71. Fate Therapeutics Company Details
    Table 72. Fate Therapeutics Business Overview
    Table 73. Fate Therapeutics Natural Killer Cells Therapeutics Product
    Table 74. Fate Therapeutics Revenue in Natural Killer Cells Therapeutics Business (2016-2021) & (US$ Million)
    Table 75. Fate Therapeutics Recent Development
    Table 76. Fortress Biotech Company Details
    Table 77. Fortress Biotech Business Overview
    Table 78. Fortress Biotech Natural Killer Cells Therapeutics Product
    Table 79. Fortress Biotech Revenue in Natural Killer Cells Therapeutics Business (2016-2021) & (US$ Million)
    Table 80. Fortress Biotech Recent Development
    Table 81. Glycostem Therapeutics Company Details
    Table 82. Glycostem Therapeutics Business Overview
    Table 83. Glycostem Therapeutics Natural Killer Cells Therapeutics Product
    Table 84. Glycostem Therapeutics Revenue in Natural Killer Cells Therapeutics Business (2016-2021) & (US$ Million)
    Table 85. Glycostem Therapeutics Recent Development
    Table 86. Innate Pharma Company Details
    Table 87. Innate Pharma Business Overview
    Table 88. Innate Pharma Natural Killer Cells Therapeutics Product
    Table 89. Innate Pharma Revenue in Natural Killer Cells Therapeutics Business (2016-2021) & (US$ Million)
    Table 90. Innate Pharma Recent Development
    Table 91. Nantkwest Company Details
    Table 92. Nantkwest Business Overview
    Table 93. Nantkwest Natural Killer Cells Therapeutics Product
    Table 94. Nantkwest Revenue in Natural Killer Cells Therapeutics Business (2016-2021) & (US$ Million)
    Table 95. Nantkwest Recent Development
    Table 96. Nkarta Therapeutics Company Details
    Table 97. Nkarta Therapeutics Business Overview
    Table 98. Nkarta Therapeutics Revenue in Natural Killer Cells Therapeutics Business (2016-2021) & (US$ Million)
    Table 99. Nkarta Therapeutics Recent Development
    Table 100. NKT Therapeutics Company Details
    Table 101. NKT Therapeutics Business Overview
    Table 102. NKT Therapeutics Natural Killer Cells Therapeutics Product
    Table 103. NKT Therapeutics Revenue in Natural Killer Cells Therapeutics Business (2016-2021) & (US$ Million)
    Table 104. NKT Therapeutics Recent Development
    Table 105. Ziopharm Oncology Company Details
    Table 106. Ziopharm Oncology Business Overview
    Table 107. Ziopharm Oncology Natural Killer Cells Therapeutics Product
    Table 108. Ziopharm Oncology Revenue in Natural Killer Cells Therapeutics Business (2016-2021) & (US$ Million)
    Table 109. Ziopharm Oncology Recent Development
    Table 110. Research Programs/Design for This Report
    Table 111. Key Data Information from Secondary Sources
    Table 112. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Natural Killer Cells Therapeutics Market Share by Type: 2020 VS 2027
    Figure 2. NK Cell Therapies Features
    Figure 3. NK Cell Directed Antibodies Features
    Figure 4. Global Natural Killer Cells Therapeutics Market Share by Application: 2020 VS 2027
    Figure 5. Research Centers & Institutes Case Studies
    Figure 6. Hospitals Case Studies
    Figure 7. Others Case Studies
    Figure 8. Natural Killer Cells Therapeutics Report Years Considered
    Figure 9. Global Natural Killer Cells Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 10. Global Natural Killer Cells Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 11. Global Natural Killer Cells Therapeutics Market Share by Regions: 2020 VS 2027
    Figure 12. Global Natural Killer Cells Therapeutics Market Share by Regions (2022-2027)
    Figure 13. Global Natural Killer Cells Therapeutics Market Share by Players in 2020
    Figure 14. Global Top Natural Killer Cells Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Natural Killer Cells Therapeutics as of 2020
    Figure 15. The Top 10 and 5 Players Market Share by Natural Killer Cells Therapeutics Revenue in 2020
    Figure 16. Global Natural Killer Cells Therapeutics Revenue Market Share by Type (2016-2021)
    Figure 17. Global Natural Killer Cells Therapeutics Revenue Market Share by Type (2022-2027)
    Figure 18. North America Natural Killer Cells Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 19. North America Natural Killer Cells Therapeutics Market Share by Type (2016-2027)
    Figure 20. North America Natural Killer Cells Therapeutics Market Share by Application (2016-2027)
    Figure 21. North America Natural Killer Cells Therapeutics Market Share by Country (2016-2027)
    Figure 22. United States Natural Killer Cells Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 23. Canada Natural Killer Cells Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 24. Europe Natural Killer Cells Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Europe Natural Killer Cells Therapeutics Market Share by Type (2016-2027)
    Figure 26. Europe Natural Killer Cells Therapeutics Market Share by Application (2016-2027)
    Figure 27. Europe Natural Killer Cells Therapeutics Market Share by Country (2016-2027)
    Figure 28. Germany Natural Killer Cells Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 29. France Natural Killer Cells Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. U.K. Natural Killer Cells Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. Italy Natural Killer Cells Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Russia Natural Killer Cells Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Nordic Natural Killer Cells Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Asia-Pacific Natural Killer Cells Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Asia-Pacific Natural Killer Cells Therapeutics Market Share by Type (2016-2027)
    Figure 36. Asia-Pacific Natural Killer Cells Therapeutics Market Share by Application (2016-2027)
    Figure 37. Asia-Pacific Natural Killer Cells Therapeutics Market Share by Region (2016-2027)
    Figure 38. China Natural Killer Cells Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. Japan Natural Killer Cells Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. South Korea Natural Killer Cells Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Southeast Asia Natural Killer Cells Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. India Natural Killer Cells Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Australia Natural Killer Cells Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. Latin America Natural Killer Cells Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Latin America Natural Killer Cells Therapeutics Market Share by Type (2016-2027)
    Figure 46. Latin America Natural Killer Cells Therapeutics Market Share by Application (2016-2027)
    Figure 47. Latin America Natural Killer Cells Therapeutics Market Share by Country (2016-2027)
    Figure 48. Mexico Natural Killer Cells Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. Brazil Natural Killer Cells Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Middle East & Africa Natural Killer Cells Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Middle East & Africa Natural Killer Cells Therapeutics Market Share by Type (2016-2027)
    Figure 52. Middle East & Africa Natural Killer Cells Therapeutics Market Share by Application (2016-2027)
    Figure 53. Middle East & Africa Natural Killer Cells Therapeutics Market Share by Country (2016-2027)
    Figure 54. Turkey Natural Killer Cells Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 55. Saudi Arabia Natural Killer Cells Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. UAE Natural Killer Cells Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. Affimed Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2016-2021)
    Figure 58. Celgene Corporation Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2016-2021)
    Figure 59. Fate Therapeutics Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2016-2021)
    Figure 60. Fortress Biotech Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2016-2021)
    Figure 61. Glycostem Therapeutics Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2016-2021)
    Figure 62. Innate Pharma Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2016-2021)
    Figure 63. Nantkwest Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2016-2021)
    Figure 64. Nkarta Therapeutics Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2016-2021)
    Figure 65. NKT Therapeutics Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2016-2021)
    Figure 66. Ziopharm Oncology Revenue Growth Rate in Natural Killer Cells Therapeutics Business (2016-2021)
    Figure 67. Bottom-up and Top-down Approaches for This Report
    Figure 68. Data Triangulation
    Figure 69. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Affimed
Celgene Corporation
Fate Therapeutics
Fortress Biotech
Glycostem Therapeutics
Innate Pharma
Nantkwest
Nkarta Therapeutics
NKT Therapeutics
Ziopharm Oncology
Frequently Asked Questions
Natural Killer Cells Therapeutics report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Natural Killer Cells Therapeutics report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Natural Killer Cells Therapeutics report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports